Resapp Health Ltd
ASX:RAP
Resapp Health Ltd
Research & Development
Resapp Health Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Resapp Health Ltd
ASX:RAP
|
Research & Development
-AU$5.8m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-37%
|
|
|
4DMedical Ltd
ASX:4DX
|
Research & Development
-AU$852.4k
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CogState Ltd
ASX:CGS
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pro Medicus Ltd
ASX:PME
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Alcidion Group Ltd
ASX:ALC
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Artrya Ltd
ASX:AYA
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Resapp Health Ltd
Glance View
ResApp Health Ltd. engages in the research and commercial development of ResApp technology for the purpose of providing health care solutions for respiratory disease. The company is headquartered in Brisbane, Queensland. The company went IPO on 2005-01-12. The Company’s digital healthcare solutions assists doctors and patients to diagnose and manage respiratory disease. The firm has developed a platform for diagnosing respiratory disease using the sound of a patient’s cough. The platform is based on sound alone and does not require physical contact with the patient. With smartphones integrating microphones, the platform can be delivered without the need for additional hardware. The firm has developed smartphone-based machine learning algorithms, which can identify exacerbations in patients with asthma or COPD. The company also has ongoing clinical programs investigating the use of these techniques to measure exacerbation severity and lung function. The firm has developed an obstructive sleep aponia screening test that uses overnight breathing and snoring sounds recorded on a smartphone placed on the bedside table.
See Also
What is Resapp Health Ltd's Research & Development?
Research & Development
-5.8m
AUD
Based on the financial report for Jun 30, 2022, Resapp Health Ltd's Research & Development amounts to -5.8m AUD.
What is Resapp Health Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-37%
Over the last year, the Research & Development growth was -36%. The average annual Research & Development growth rates for Resapp Health Ltd have been 3% over the past three years , -11% over the past five years , and -37% over the past ten years .
